APT Medical Inc.: CITIC Securities Co., Ltd.'s special review opinion on the differentiated equity distribution, special dividend and interest exclusion of Shenzhen Apt Medical Inc.'s instruments.
APT Medical Inc.: Announcement of Annual Equity Distribution Implementation in 2023
CITIC Securities Co., Ltd.'s special review opinion on the differentiated equity distribution, special dividend and interest exclusion of Shenzhen Apt Medical Inc.'s instruments.
Announcement of Annual Equity Distribution Implementation in 2023
Announcement on Adjusting the Total Amount of Cash Dividends and the Total Amount of Capital Reserve Transferred to Share Capital in the Profit Distribution of 2023
Announcement of the first grant of and reserved grant of Class A Restricted Stocks and the first grant result of Class B Restricted Stocks in the restricted stock incentive plan of the company for 2021 and the listing of shares.
Announcement of Resolutions of the Shareholders' Meeting for the Fiscal Year 2023
Legal opinion from Jia Yuan Law Firm, Peking regarding the 2023 Shareholder's Annual Meeting of Apt Medical Inc. based in Shenzhen, specializing in medical instruments.
Materials for the 2023 Annual Shareholders Meeting.
Announcement regarding the first granting and reserved partial granting of type A restricted stocks and type B restricted stocks for the first and second vesting periods, respectively, of the company's restricted stock incentive plan for 2021.
Legal Opinion on the first grant of restricted stocks and reserved grant of restricted stocks, achievement of ownership conditions for the first vesting period of Class A restricted stocks and the second vesting period of Class B restricted stocks, and the cancellation of some restricted stocks related matters for Shenzhen Apt Medical Inc.'s 2021 restricted stock incentive plan for medical instruments
Resolution of the Second Independent Director's Meeting in 2024.
Announcement of the Resolution of the 13th Meeting of the Second Board of Supervisors.
The Supervisory Board's opinion on the verification of the first attribution period of the restricted stock incentive plan for the company in 2021, as well as the reserved grant of A-type restricted stocks and the second attribution period of B-type restricted stocks.
Announcement of the Resolution of the 16th Meeting of the Second Board of Directors.
Announcement regarding the cancellation of the portion of the 2021 restricted stock incentive plan that has been granted but not yet vested.
Notice on the convening of the 2023 annual shareholder meeting.
Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Legal Opinion of Beijing Jiayuan Law Firm on the 2024 Second Extraordinary General Meeting of Shareholders of Shenzhen Huitai Medical Devices Co., Ltd.
Announcement of Resolutions of the 12th Meeting of the Second Board of Supervisors
No Data